カテゴリ： 世界, 医療/バイオ, QYResearch

胃腸の世界市場2023年：医療用胃腸薬、一般用胃腸薬

■ 英語タイトル：Global Gastrointestinal Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8769）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8769
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[胃腸の世界市場2023年：医療用胃腸薬、一般用胃腸薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は胃腸のグローバル市場について調査・分析し、世界の胃腸市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（医療用胃腸薬、一般用胃腸薬）、用途別セグメント分析（慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AstraZenec、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria（Tillotts）、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssenなどが含まれています。胃腸のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、胃腸市場規模を算出する際に考慮しました。

・胃腸市場の概要
- 胃腸の種類別セグメント
- 世界の胃腸市場規模：タイプ別分析（医療用胃腸薬、一般用胃腸薬）
- 胃腸の用途別セグメント
- 世界の胃腸市場規模：用途別分析（慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他）
- 世界の胃腸市場規模予測（2018年-2029年）

・胃腸市場の成長トレンド
- 胃腸の地域別市場規模（2018年-2029年）
- 胃腸市場ダイナミクス
- 胃腸の業界動向
- 胃腸市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：医療用胃腸薬、一般用胃腸薬
- 世界の胃腸のタイプ別市場規模（2018年-2023年）
- 世界の胃腸のタイプ別市場規模（2024年-2029年）

・用途別セグメント：慢性胃炎、機能性ディスペプシア、消化性潰瘍、急性胃腸炎、その他
- 世界の胃腸の用途別市場規模（2018年-2023年）
- 世界の胃腸の用途別市場規模（2024年-2029年）

・胃腸の地域別市場規模
- 北米の胃腸市場規模（2018年-2029年）
- 米国の胃腸市場規模（2018年-2029年）
- ヨーロッパの胃腸市場規模（2018年-2029年）
- アジア太平洋の胃腸市場規模（2018年-2029年）
- 中国の胃腸市場規模（2018年-2029年）
- 日本の胃腸市場規模（2018年-2029年）
- 韓国の胃腸市場規模（2018年-2029年）
- インドの胃腸市場規模（2018年-2029年）
- オーストラリアの胃腸市場規模（2018年-2029年）
- 中南米の胃腸市場規模（2018年-2029年）
- 中東・アフリカの胃腸市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
AstraZenec、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria（Tillotts）、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssen

・アナリストの観点/結論

・調査手法と情報源

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn’s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Highlights
The global Gastrointestinal market was valued at US$ 35990 million in 2022 and is anticipated to reach US$ 43730 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.
The Gastrointestinal market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastrointestinal companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Market Perspective (2018-2029)
2.2 Gastrointestinal Growth Trends by Region
2.2.1 Global Gastrointestinal Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gastrointestinal Historic Market Size by Region (2018-2023)
2.2.3 Gastrointestinal Forecasted Market Size by Region (2024-2029)
2.3 Gastrointestinal Market Dynamics
2.3.1 Gastrointestinal Industry Trends
2.3.2 Gastrointestinal Market Drivers
2.3.3 Gastrointestinal Market Challenges
2.3.4 Gastrointestinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Players by Revenue
3.1.1 Global Top Gastrointestinal Players by Revenue (2018-2023)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Revenue
3.4 Global Gastrointestinal Market Concentration Ratio
3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2022
3.5 Gastrointestinal Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Product Solution and Service
3.7 Date of Enter into Gastrointestinal Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Breakdown Data by Type
4.1 Global Gastrointestinal Historic Market Size by Type (2018-2023)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2024-2029)
5 Gastrointestinal Breakdown Data by Application
5.1 Global Gastrointestinal Historic Market Size by Application (2018-2023)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gastrointestinal Market Size (2018-2029)
6.2 North America Gastrointestinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gastrointestinal Market Size by Country (2018-2023)
6.4 North America Gastrointestinal Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Market Size (2018-2029)
7.2 Europe Gastrointestinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gastrointestinal Market Size by Country (2018-2023)
7.4 Europe Gastrointestinal Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size (2018-2029)
8.2 Asia-Pacific Gastrointestinal Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gastrointestinal Market Size by Region (2018-2023)
8.4 Asia-Pacific Gastrointestinal Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Market Size (2018-2029)
9.2 Latin America Gastrointestinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gastrointestinal Market Size by Country (2018-2023)
9.4 Latin America Gastrointestinal Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Market Size (2018-2029)
10.2 Middle East & Africa Gastrointestinal Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gastrointestinal Market Size by Country (2018-2023)
10.4 Middle East & Africa Gastrointestinal Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZenec
11.1.1 AstraZenec Company Detail
11.1.2 AstraZenec Business Overview
11.1.3 AstraZenec Gastrointestinal Introduction
11.1.4 AstraZenec Revenue in Gastrointestinal Business (2018-2023)
11.1.5 AstraZenec Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gastrointestinal Introduction
11.2.4 Sanofi Revenue in Gastrointestinal Business (2018-2023)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Gastrointestinal Introduction
11.3.4 Bayer Revenue in Gastrointestinal Business (2018-2023)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gastrointestinal Introduction
11.4.4 Pfizer Revenue in Gastrointestinal Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Introduction
11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Gastrointestinal Introduction
11.6.4 Teva Revenue in Gastrointestinal Business (2018-2023)
11.6.5 Teva Recent Development
11.7 Zeria（Tillotts）
11.7.1 Zeria（Tillotts） Company Detail
11.7.2 Zeria（Tillotts） Business Overview
11.7.3 Zeria（Tillotts） Gastrointestinal Introduction
11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2018-2023)
11.7.5 Zeria（Tillotts） Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Detail
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Gastrointestinal Introduction
11.8.4 Perrigo Revenue in Gastrointestinal Business (2018-2023)
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Introduction
11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2018-2023)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Detail
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Gastrointestinal Introduction
11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2018-2023)
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Detail
11.11.2 C.B. Fleet Business Overview
11.11.3 C.B. Fleet Gastrointestinal Introduction
11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2018-2023)
11.11.5 C.B. Fleet Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Gastrointestinal Introduction
11.12.4 Abbott Revenue in Gastrointestinal Business (2018-2023)
11.12.5 Abbott Recent Development
11.13 Jiangzhong
11.13.1 Jiangzhong Company Detail
11.13.2 Jiangzhong Business Overview
11.13.3 Jiangzhong Gastrointestinal Introduction
11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2018-2023)
11.13.5 Jiangzhong Recent Development
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Detail
11.14.2 Xian-Janssen Business Overview
11.14.3 Xian-Janssen Gastrointestinal Introduction
11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2018-2023)
11.14.5 Xian-Janssen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Prescription Gastrointestinal Drug
Table 3. Key Players of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Gastrointestinal Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Gastrointestinal Market Share by Region (2018-2023)
Table 8. Global Gastrointestinal Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Gastrointestinal Market Share by Region (2024-2029)
Table 10. Gastrointestinal Market Trends
Table 11. Gastrointestinal Market Drivers
Table 12. Gastrointestinal Market Challenges
Table 13. Gastrointestinal Market Restraints
Table 14. Global Gastrointestinal Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Gastrointestinal Market Share by Players (2018-2023)
Table 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2022)
Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Product Solution and Service
Table 21. Date of Enter into Gastrointestinal Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Gastrointestinal Revenue Market Share by Type (2018-2023)
Table 25. Global Gastrointestinal Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Gastrointestinal Revenue Market Share by Type (2024-2029)
Table 27. Global Gastrointestinal Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Gastrointestinal Revenue Market Share by Application (2018-2023)
Table 29. Global Gastrointestinal Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Gastrointestinal Revenue Market Share by Application (2024-2029)
Table 31. North America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gastrointestinal Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Gastrointestinal Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Gastrointestinal Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Gastrointestinal Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Gastrointestinal Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Gastrointestinal Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Gastrointestinal Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Gastrointestinal Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Gastrointestinal Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Gastrointestinal Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Gastrointestinal Market Size by Country (2024-2029) & (US$ Million)
Table 46. AstraZenec Company Detail
Table 47. AstraZenec Business Overview
Table 48. AstraZenec Gastrointestinal Product
Table 49. AstraZenec Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 50. AstraZenec Recent Development
Table 51. Sanofi Company Detail
Table 52. Sanofi Business Overview
Table 53. Sanofi Gastrointestinal Product
Table 54. Sanofi Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 55. Sanofi Recent Development
Table 56. Bayer Company Detail
Table 57. Bayer Business Overview
Table 58. Bayer Gastrointestinal Product
Table 59. Bayer Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 60. Bayer Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Gastrointestinal Product
Table 64. Pfizer Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gastrointestinal Product
Table 69. GlaxoSmithKline Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Teva Company Detail
Table 72. Teva Business Overview
Table 73. Teva Gastrointestinal Product
Table 74. Teva Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Zeria（Tillotts） Company Detail
Table 77. Zeria（Tillotts） Business Overview
Table 78. Zeria（Tillotts） Gastrointestinal Product
Table 79. Zeria（Tillotts） Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 80. Zeria（Tillotts） Recent Development
Table 81. Perrigo Company Detail
Table 82. Perrigo Business Overview
Table 83. Perrigo Gastrointestinal Product
Table 84. Perrigo Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 85. Perrigo Recent Development
Table 86. Boehringer Ingelheim Company Detail
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Gastrointestinal Product
Table 89. Boehringer Ingelheim Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Purdue Pharma Company Detail
Table 92. Purdue Pharma Business Overview
Table 93. Purdue Pharma Gastrointestinal Product
Table 94. Purdue Pharma Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 95. Purdue Pharma Recent Development
Table 96. C.B. Fleet Company Detail
Table 97. C.B. Fleet Business Overview
Table 98. C.B. Fleet Gastrointestinal Product
Table 99. C.B. Fleet Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 100. C.B. Fleet Recent Development
Table 101. Abbott Company Detail
Table 102. Abbott Business Overview
Table 103. Abbott Gastrointestinal Product
Table 104. Abbott Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Jiangzhong Company Detail
Table 107. Jiangzhong Business Overview
Table 108. Jiangzhong Gastrointestinal Product
Table 109. Jiangzhong Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 110. Jiangzhong Recent Development
Table 111. Xian-Janssen Company Detail
Table 112. Xian-Janssen Business Overview
Table 113. Xian-Janssen Gastrointestinal Product
Table 114. Xian-Janssen Revenue in Gastrointestinal Business (2018-2023) & (US$ Million)
Table 115. Xian-Janssen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Gastrointestinal Market Share by Type: 2022 VS 2029
Figure 3. Prescription Gastrointestinal Drug Features
Figure 4. OTC Gastrointestinal Drug Features
Figure 5. Global Gastrointestinal Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Gastrointestinal Market Share by Application: 2022 VS 2029
Figure 7. Chronic Gastritis Case Studies
Figure 8. Functional Dyspepsia Case Studies
Figure 9. Peptic Ulcer Case Studies
Figure 10. Acute Gastroenteritis Case Studies
Figure 11. Others Case Studies
Figure 12. Gastrointestinal Report Years Considered
Figure 13. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Gastrointestinal Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Gastrointestinal Market Share by Region: 2022 VS 2029
Figure 16. Global Gastrointestinal Market Share by Players in 2022
Figure 17. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2022
Figure 19. North America Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Gastrointestinal Market Share by Country (2018-2029)
Figure 21. United States Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Gastrointestinal Market Share by Country (2018-2029)
Figure 25. Germany Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Gastrointestinal Market Share by Region (2018-2029)
Figure 33. China Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Gastrointestinal Market Share by Country (2018-2029)
Figure 41. Mexico Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Gastrointestinal Market Share by Country (2018-2029)
Figure 45. Turkey Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Gastrointestinal Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 48. Sanofi Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 50. Pfizer Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 52. Teva Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 53. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 54. Perrigo Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 55. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 56. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 57. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 58. Abbott Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 59. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 60. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 細胞培養プロセス開発の世界市場2023年：上流工程開発、下流工程開発
  • 全身性アスペルギルス症/全身性カンジダ症治療の世界市場2023年：ボリコナゾール、リポソームアムホテリシンB、全身経口アゾール、外用抗真菌剤、その他
  • 消化管病原体パネルの世界市場インサイト・予測（～2028年）
  • KNX認定製品の世界市場2023年：エネルギー管理、HVACシステム、ブラインド＆シャッター、メーター、リモコン、監視システム、火災＆煙検出、白物家電、照明
  • プライベートセキュリティサービスの世界市場2023年：警備、警報監視、装甲輸送、私立探偵、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8769 )"胃腸の世界市場2023年：医療用胃腸薬、一般用胃腸薬" (英文：Global Gastrointestinal Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。